Literature DB >> 17927680

Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion.

Olga S León Fernández1, Hussam H Ajamieh, Jorge Berlanga, Silvia Menéndez, Renate Viebahn-Hánsler, Lamberto Re, Anna M Carmona.   

Abstract

The liver is damaged by sustained ischemia in liver transplantation, and the reperfusion after ischemia results in further functional impairment. Ozone oxidative preconditioning (OzoneOP) protected the liver against ischemia/reperfusion (I/R) injury. The aim of this study was to investigate the role of A(1) adenosine receptor on the protective actions conferred by OzoneOP in hepatic I/R. By using a specific agonist and antagonist of the A(1) subtype receptor (2-chloro N6 cyclopentyladenosine, CCPA and 8-cyclopentyl-1,3-dipropylxanthine, DPCPX respectively), we studied the role of A(1) receptor in the protective effects of OzoneOP on the liver damage, nitiric oxide (NO) generation, adenosine deaminase activity and preservation of the cellular redox balance. Immunohistochemical analysis of nuclear factor-kappa B (NF-kappaB), tumor necrosis factor alpha (TNF-alpha) and heat shock protein-70 (HSP-70) was performed. OzoneOP prevented and/or ameliorated ischemic damage. CCPA showed a similar effect to OzoneOP + I/R group. A(1)AR antagonist DPCPX blocked the protective effect of OzoneOP. OzoneOP largely reduced the intensity of the p65 expression, diminished TNF-alpha production, and promoted a reduction in HSP-70 immunoreactivity. In summary, OzoneOP exerted protective effects against liver I/R injury through activation of A(1) adenosine receptors (A(1)AR). Adenosine and (.)NO produced by OzoneOP may play a role in the pathways of cellular signalling which promote preservation of the cellular redox balance, mitochondrial function, glutathione pools as well as the regulation of NF-kappaB and HSP-70.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927680     DOI: 10.1111/j.1432-2277.2007.00568.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Targeting of adenosine receptors in ischemia-reperfusion injury.

Authors:  Victor E Laubach; Brent A French; Mark D Okusa
Journal:  Expert Opin Ther Targets       Date:  2010-11-29       Impact factor: 6.902

Review 2.  Purinergic signalling in the liver in health and disease.

Authors:  Geoffrey Burnstock; Byron Vaughn; Simon C Robson
Journal:  Purinergic Signal       Date:  2013-11-24       Impact factor: 3.765

3.  Adenosine and inosine exert cytoprotective effects in an in vitro model of liver ischemia-reperfusion injury.

Authors:  Katalin Módis; Domokos Gerő; Rita Stangl; Olivér Rosero; Attila Szijártó; Gábor Lotz; Petra Mohácsik; Petra Szoleczky; Ciro Coletta; Csaba Szabó
Journal:  Int J Mol Med       Date:  2012-12-04       Impact factor: 4.101

4.  Ozone therapy could attenuate tubulointerstitial injury in adenine-induced CKD rats by mediating Nrf2 and NF-κB.

Authors:  Gang Yu; Xiuheng Liu; Zhiyuan Chen; Hui Chen; Lei Wang; Zhishun Wang; Tao Qiu; Xiaodong Weng
Journal:  Iran J Basic Med Sci       Date:  2016-10       Impact factor: 2.699

5.  Ozone protects cardiomyocytes against ischemia/reperfusion injury: Regulating the heat shock protein 70 (HPS70) expression through activating the JAK2/STAT3 Pathway.

Authors:  Shenglong Yu; Huizhuang Guo; Yi Luo; Hanwei Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 6.  Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility.

Authors:  Noel L Smith; Anthony L Wilson; Jason Gandhi; Sohrab Vatsia; Sardar Ali Khan
Journal:  Med Gas Res       Date:  2017-10-17

Review 7.  Ozonated oil in wound healing: what has already been proven?

Authors:  Ana Paula Anzolin; Níncia Lucca da Silveira-Kaross; Charise Dallazem Bertol
Journal:  Med Gas Res       Date:  2020 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.